SPONSOR
University of Miami
Total Trials
22
Recruiting
22
Phases
Phase 2, Phase 4
Conditions studied: Laryngeal Squamous Cell CarcinomaActivity, MotorDepressionCannabis Use DisorderHIVHER2-positive Breast CancerAdvanced Breast CancerFuchs' Endothelial DystrophyCorneal EdemaAmyotrophic Lateral Sclerosis
University of Miami is a clinical research sponsor with 22 registered studies on ClinicalTrials.gov, of which 22 are actively recruiting participants. Research covers conditions including Laryngeal Squamous Cell Carcinoma, Activity, Motor, Depression, Cannabis Use Disorder.
The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Miami
How many clinical trials has University of Miami sponsored?
ClinicalMetric currently tracks 22 clinical trials sponsored by University of Miami, of which 22 are actively recruiting participants. These trials cover conditions including Laryngeal Squamous Cell Carcinoma, Activity, Motor, Depression. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Miami research focus on?
University of Miami clinical trials span Laryngeal Squamous Cell Carcinoma, Activity, Motor, Depression, Cannabis Use Disorder, HIV, and additional conditions. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Miami clinical trial?
To participate in a University of Miami trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Miami trials with current recruitment status updated daily.
Clinical Trials by University of Miami
NCT07392580 Phase 2
Recruiting
Intralesional Chemotherapy (IC): Cisplatin + Epinephrine
Laryngeal Squamous Cell Carcinoma
NCT07378826
Recruiting
Power Training Progression Methods
Activity, Motor
NCT05453513
Recruiting
The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV
Depression
NCT06123988
Recruiting
Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
HER2-positive Breast Cancer
NCT06261346
Recruiting
Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
Fuchs' Endothelial Dystrophy
NCT00317616
Recruiting
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study
Amyotrophic Lateral Sclerosis
NCT06038721
Recruiting
Unified Protocol: Community Connections
Mental Health Issue
NCT06494033
Recruiting
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
Lung Diseases
NCT07217678 Phase 4
Recruiting
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
Glaucoma
NCT05454267
Recruiting
Early Detection of Vaping-related Vascular Diseases
Vaping
NCT05459207
Recruiting
Association Between Body Composition and Pain in Spinal Cord Injury
Pain
NCT05842044 Phase 2
Recruiting
NSAID Use After Robotic Partial Nephrectomy
Kidney Cancer
NCT06997081 Phase 2
Recruiting
ERd Combination Treatment in Newly Diagnosed Multiple Myeloma
Multiple Myeloma
NCT05142605
Recruiting
Evaluation of Grief Therapy Approaches for Bereaved Parents
Grief
NCT05296070 Phase 2
Recruiting
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
Marginal Zone Lymphoma
NCT06902285 Phase 4
Recruiting
Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty
Sleep
NCT07446777
Recruiting
FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
Multiple Myeloma
NCT06124508
Recruiting
PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors
Head and Neck Cancer
NCT06489262
Recruiting
Efficacy Trial of Healthy Together ("Juntos")
Obesity
NCT06506435
Recruiting
Radiotherapy Patient Education With Virtual Reality
Anxiety
NCT04650256
Recruiting
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences
Skin Toxicity
NCT05839210
Recruiting
Lifestyle Intervention of Food and Exercise for Lymphoma Survivors
Non Hodgkin Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology